M&A

Innophos increases focus on dietary supplements through $125m acquisition of Novel Ingredients

Photo: iStock/Macgyverhh

The NASDAQ-traded firm Innophos Holdings has entered into a definitive merger agreement to acquire Novel Ingredients for $125m, bumping up the share of its food, health, and nutrition segment within the company.

The private equity firm will be the majority owner of Nature's bounty. ©iStock

KKR signs deal to acquire majority stake in Nature's Bounty

© iStock/Kritchanut

Lonza completes Capsugel acquisition for $5.5 billion

Nutraceutical International sold for $446 million

Nutraceutical International sold for $446 million

Photo: iStock/psisa

Sanat Products plans more acquisitions after snapping up Hindustan Herbals Limited

© iStock/pichet_w

Chinese investment in supplements expected to continue: NCN

Glanbia strengthens performance nutrition offering with €181 million double deal

Glanbia strengthens performance nutrition offering with €181 million double deal

DSM’s i-Health acquires UP4 probiotics brand

DSM’s i-Health acquires UP4 probiotics brand

Reckitt Benckiser and Mead Johnson Nutrition have both confirmed that discussions are taking place over a potential takeover of the US nutrition company.

Reckitt Benckiser in $16.7bn takeover bid for Mead Johnson Nutrition

Omega Protein starts dividend program

Omega Protein starts dividend program

More M&A